We previously performed a genome-wide linkage scan in Portuguese schizophrenia families that identified a risk locus on chromosome 5q31-q35. This finding was supported by metaanalysis of 20 other schizophrenia genome-wide scans that identified 5q23.2-q34 as the second most compelling susceptibility locus in the genome. In the present report, we took a two-stage candidate gene association approach to investigate a group of gamma-aminobutyric acid (GABA) A receptor subunit genes (GABRA1, GABRA6, GABRB2, GABRG2, and GABRP) within our linkage peak. These genes are plausible candidates based on prior evidence for GABA system involvement in schizophrenia. In the first stage, associations were detected in a Portuguese patient sample with single nucleotide polymorphisms (SNPs) and haplotypes in GABRA1 (P ¼ 0.00062-0.048), GABRP (P ¼ 0.0024-0.042), and GABRA6 (P ¼ 0.0065-0.0088). The GABRA1 and GABRP findings were replicated in the second stage in an independent German family-based sample (P ¼ 0.0015-0.043). Supportive evidence for association was also obtained for a previously reported GABRB2 risk haplotype. Exploratory analyses of the effects of associated GABRA1 haplotypes on transcript levels found altered expression of GABRA6 and coexpressed genes of GABRA1 and GABRB2. Comparison of transcript levels in schizophrenia patients and unaffected siblings found lower patient expression of GABRA6 and coexpressed genes of GABRA1. Interestingly, the GABRA1 coexpressed genes include synaptic and vesicle-associated genes previously found altered in schizophrenia prefrontal cortex. Taken together, these results support the involvement of the chromosome 5q GABA A receptor gene cluster in schizophrenia, and suggest that schizophrenia-associated haplotypes may alter expression of GABA-related genes.
Introduction
Schizophrenia is a complex psychiatric disorder with a strong genetic component. 1, 2 Nearly 40 independent genome-wide linkage scans of schizophrenia have been conducted to date. Meta-analysis of 20 of these scans identified chromosome 5q23.2-q34 from D5S2098 to D5S422 (123.8-162.1 Mb; National Center for Biotechnology Information (NCBI) Build 35 human genome assembly) as the second most significant risk locus in the genome. 38 Subsequently, we reported linkage to an overlapping region at chromosome 5q31.1-q35.1 in a genome-wide scan of schizophrenia and schizoaffective depressed type (SA-D) families of Portuguese descent. 32 The maximum linkage signal in 29 families was an NPL ¼ 3.09 (P ¼ 0.0012) at marker D5S820, falling just short of genome-wide significance based on simulations of the data. 32 Higher density mapping in an expanded sample of 40 pedigrees produced a peak NPL ¼ 3.28 (P ¼ 0.00066) in the same region. Nominally significant linkage was obtained across a B35 cM region from D5S816 to D5S1456 located from 135.3 to 169 Mb. Although the 5q risk locus is large, the strength and consistency of the linkage findings warrants candidate gene association studies to identify the underlying schizophrenia risk gene.
The chromosome 5q risk locus contains a cluster of gamma-aminobutyric acid (GABA) A receptor subunit genes, GABRB2, GABRA6, GABRA1, and GABRG2, which are grouped within an 860-kb region at 5q34 that is B4 Mb telomeric to our peak at D5S820. A fifth GABA A receptor subunit gene, GABRP, is located B12 Mb telomeric to our peak at the boundary of our linkage region, which nevertheless could be within range to produce this linkage signal. As reviewed by Steiger and Russek, 39 the GABA A receptor is a neuronal ligand-gated ion channel that is the major inhibitory receptor in the adult brain via its function in triggering chloride ion influx, resulting in cell hyperpolarization. Numerous receptor subunits have been identified and each displays different temporal and spatial patterns of expression. The subunits assemble into pentamers, typically of two alpha, two beta, and one gamma subunit. The most widely expressed GABA A receptor in the adult brain is composed of alpha 1, beta 2, and gamma 2 subunits, encoded by GABRA1, GABRB2, and GABRG2, respectively. These three genes are all located in the 5q GABA A receptor subunit gene cluster. The cluster also contains GABRA6 that encodes the alpha 6 subunit expressed in granule cells of the cerebellum and the cochlea. 40 The pi subunit encoded by GABRP, which influences drug effects on the receptor, 41 has been detected in the hippocampus and temporal cortex, as well as several peripheral tissues. 42 The 5q GABA genes are plausible candidates for the schizophrenia risk gene in the 5q locus based on a converging body of literature implicating GABA system dysfunction in schizophrenia pathophysiology. [43] [44] [45] [46] [47] [48] [49] In schizophrenia patient brain samples, markers of GABAergic neurons are reduced in expression and postsynaptic receptor complexes are increased in number. 47, 50, 51 Furthermore, there is evidence that neuregulin 1 (NRG1) and dysbindin (DTNBP1), two schizophrenia candidate risk genes, 33, [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] interact with the GABA A receptor. For example, treatment of the rat hippocampus with NRG1 resulted in lower expression of GABA A receptor subunit transcripts, 66 while dysbindin likely colocalizes with GABA A receptor subunits in the hippocampus, cortex, and cerebellum through its association with beta-dystrobrevin in the dystrophin protein complex. [67] [68] [69] Despite the evidence for GABA system alterations in schizophrenia patients, there has been little investigation of association between GABA receptor genes and schizophrenia, although association with the GABRB2 gene was recently reported in a Chinese patient sample. 70 We performed an association study of the 5q GABA A receptor subunit gene cluster in schizophrenia based on: (1) strong meta-analytic evidence for linkage between schizophrenia and chromosome 5q, (2) linkage to 5q in our Portuguese schizophrenia families, (3) evidence for involvement of the GABA system in schizophrenia, and (4) location of the GABA A receptor subunit gene cluster in the 5q risk locus. To increase the chance of detecting association, we screened a Portuguese patient sample that was ascertained in the same manner as the Portuguese family sample, which demonstrated linkage to 5q. Positive associations were followed up in an independent sample of German patients. We subsequently explored whether GABA A receptor subunit gene haplotypes that were found to be associated with schizophrenia were related to altered transcript levels of the GABA A genes and groups of GABA-related genes. We also tested for disease-related expression differences in schizophrenia patients compared to their unaffected siblings. Our findings provide evidence for associations between schizophrenia and the GABRA1, GABRP, and GABRB2 genes, and suggest relationships between disease-associated haplotypes and transcript expression, as well as disease-specific transcript alterations.
Materials and methods

Subjects
Characteristics of the samples utilized in the current study are provided in Table 1 .
Portuguese-descent association and microarray mRNA expression samples The subjects utilized in our association analyses and microarray expression analyses originated from continental Portugal and the islands of the Azores and Madeira, and have been previously described. 32 Unrelated patients and control individuals were also ascertained from the Azorean immigrant population of Fall River, USA, and were confirmed to have all four grandparents from the Azores, Madeira, or continental Portugal. Controls consisted of unrelated individuals ascertained through a brochure left in community facilities (eg churches, community centers, doctor's offices, large employers) and four unaffected individuals that married into our linkage pedigrees. 32 Best estimate diagnoses of schizophrenia or SA-D according to DSM-IV criteria were made by two blinded researchers after review of clinical information, Diagnostic Interview 5q GABA A receptor genes confer schizophrenia risk TL Petryshen et al for Genetic Studies (DIGS), 71 Operational Criteria Checklist for Psychotic Illness (OPCRIT), 72 and written narratives. The study received approval by all appropriate Institutional Review Boards and subjects provided informed consent.
Our first-stage association sample consisted of Portuguese-descent parent-proband trios (N ¼ 111; 30% continental Portugal, 55% Azores, 15% Madiera), unrelated cases (N ¼ 321; 38% continental Portugal, 45% Azores, 17% Madiera), and control individuals (N ¼ 242; 12% continental Portugal, 85% Azores, 3% Madiera). All trio probands and cases were diagnosed with schizophrenia. In all, 12 parentproband trios and six cases were also present in our previously reported linkage pedigrees. 32 We used the Genetic Power Calculator 73 to determine that the trios sample had 28 and 44% power, and the case-control sample had 58 and 81% power, to detect a risk allele with 10% frequency and 20% frequency, respectively, with a multiplicative genotype relative risk of 1.5. Given the modest power of the separate samples, association results for the parent-proband trios and for the unrelated cases and controls were combined (described below), as the collective sample had 75 and 92% power under the same assumptions. Tests for stratification 74 using B60% of the collective sample (94 trios, 152 cases, and 149 controls) and 46 unlinked markers did not detect population substructure between the trios and case-control samples, nor between the cases and controls ( 75 and data not shown).
The Portuguese microarray mRNA expression sample has been described previously. 59 Briefly, the sample consisted of primary leukocyte cell preparations from 33 age-and gender-matched sibling pairs (22 female, 11 male pairs; 32 schizophrenia and one SA-D discordant pairs) selected from our linkage pedigrees. 32 Of the 33 sibpairs, 32 sibpairs were also genotyped for the same set of markers as the association sample. Of these individuals, 17 were cases in our association sample.
German association sample Our second-stage association sample consisted of parent-proband trios (N ¼ 238) from Germany and Hungary, and have been previously described. 76 Probands met Research Diagnostic Criteria 77 for schizophrenia (N ¼ 228) or SA-D (N ¼ 10). The study received approval by all appropriate Institutional Review Boards and subjects provided informed consent.
Genotyping
Single nucleotide polymorphisms (SNPs) spanning the 5q GABA A receptor subunit genes were selected from the NCBI dbSNP database (http:// www.ncbi.nlm.nih.gov/SNP/), the Celera Discovery System database (http://www.celeradiscoverysystem.com/), and the International HapMap Project (http://hapmap.org/). We also genotyped five GABRB2 SNPs previously reported to be associated with schizophrenia in Chinese patients 70 (rs187269, rs252944, rs194072, rs1816071, and rs6556547; note that rs6556547 in the current study is B217G1584 in the previous report). SNP Gender data missing for four Portuguese control individuals and seven German probands.
5q GABA A receptor genes confer schizophrenia risk TL Petryshen et al common haplotypes) were defined as previously described. 81 LD between haplotype blocks was determined by the Haploview program, which considers haplotypes within blocks as alleles of a multiallelic marker using Hedrick's multiallelic extension to the D 0 statistic. 82 Maximum-likelihood expectation (MLE) haplotypes within each haplotype block were reconstructed using an expectation maximization algorithm. 83 Association analyses were performed using a narrow phenotype that included schizophrenia and SA-D, which we refer to collectively as 'schizophrenia'. Single markers and MLE haplotypes were tested for association with schizophrenia by the transmission disequilibrium test (TDT) 84 for parent-proband trios, and by w 2 test for the unrelated cases and controls. Note that the trio probands were not used as cases in the case-control analyses, thus the trios and case-control samples did not overlap. Since the power of each sample was not high to detect associations with lower frequency alleles, the results for the trios sample and the case-control sample were combined. This was carried out by reformatting the TDT results and w 2 results as a mean, observed, and variance on the number of risk alleles transmitted in the trios or found in the unrelated cases. A combined standard normal Z-score was calculated, where the sum of the deviations from expected frequencies (under the null hypothesis of no association) of each sample was divided by the sum of the variances of each sample, as previously described. 59, 85 Nominal significance levels were obtained from the Z distribution. This approach provided SNP allele-or haplotype-specific nominal significance levels. Odds ratios (OR) were computed using the method of Morris and Gardner, 86 with the logit method used to calculate the OR of the combined Portuguese trios and case-control sample.
Associations that surpassed a nominal two-tailed Po0.05 in our Portuguese sample were subsequently examined in an independent German sample. Single markers and MLE haplotypes were tested for association to schizophrenia by the TDT. 84 One-tailed Pvalues, indicated by (*), are reported for the German sample for all alleles and haplotypes that were associated in the same manner as in the Portuguese sample (eg, higher frequency in Portuguese patients and overtransmitted to German trio probands). We considered an allele or haplotype to be replicated in the German sample only if the association was in the same manner with a one-tailed Po0.05*. This twostage approach has the advantage that it is not overly punitive in the first stage, but relies on replication in a second sample for support of association. Relative risks were computed as the ratio of the number of transmissions to the number of nontransmissions, as determined by the TDT. One-tailed P-values are also reported for the Portuguese and German samples for GABRB2 alleles and haplotypes that supported schizophrenia association results previously reported in a Chinese study. 70 Microarray mRNA expression methods As described previously, 59 total RNA was extracted from blood leukocyte cell preparations from discordant sibpairs selected from our Portuguese linkage pedigrees. 32 Microarray samples were labeled and processed according to standard protocols, hybridized to the Human Genome U133A GeneChips (Affymetrix), washed and stained on the Fluidics Station (Affymetrix) according to the EukGE-WS2 protocol, and scanned using the Agilent G2500A Gene Array Scanner. Scans were subjected to a priori quality control criteria and matching criteria to obtain 33 high-quality matched sibpairs for expression analyses. The scan files were normalized to a median intensity value of 500 using Affymetrix MicroArray Suite 5.0. Normalized expression data for the 5q GABA A receptor subunit genes and GABA gene sets reported in this study are available in Supplementary  Table 2 .
Validation of microarray data by real-time quantitative PCR Microarray expression levels of the discordant sibpair expression sample used in the current study have previously been successfully validated for five transcripts of interest and two reference genes using realtime quantitative RT-PCR. 59, 87 In those studies, the fold changes reported by the microarray and RT-PCR methods for the seven genes were highly correlated (r ¼ 0.95) based on triplicate assays for 19 sibpairs that had sufficient RNA for both procedures. In light of this previous work, and due to the limited amount of RNA available for validation in only a subset of the sample, we did not perform additional validation efforts in the present study.
Microarray expression data analysis
Linear regression analysis of GABA transcript expression We tested whether two GABRA1 haplotypes, Hap10A and Hap10B, that had evidence for association with schizophrenia in both our Portuguese and German association samples had an effect on transcript expression levels of the 5q GABA A receptor subunit genes. Haplotypes were determined for each individual from 32 of the 33 discordant schizophrenia sibpairs for which we had expression data. The observed frequencies of the tested haplotypes were as follows: GABRA1 Hap10A: 17% þ / þ , 52% þ /À, 31% À/À; and GABRA1 Hap10B: 0% þ / þ , 37% þ /À, 63% À/À. GABRP Hap18D, which also had evidence for association in both patient samples, was not tested because the haplotype frequency was too low to be informative for these analyses. Expression data were linearly regressed on genotypes regardless of schizophrenia diagnosis (ie, the effect of a particular haplotype was investigated in the schizophrenia and unaffected siblings together). We only tested for haplotype effects on expression of the five 5q GABA A receptor subunit genes, GABRA1, GABRA6, GABRB2, 5q GABA A receptor genes confer schizophrenia risk TL Petryshen et al GABRG2, and GABRP. We utilized the standard biometrical model 88 with additive effect only. For GABRA1 Hap10A, we also tested an additive þ dominant model, since all three genetic classes were observed in the sample. Thus, a total of 15 tests were performed (five transcripts Â three genetic models (Hap10A: two models þ Hap10B: one model)). Significance of each model was assessed by F-test, and the additive and additive þ dominant models for Hap10A were compared by ANOVA to determine if there was a significant dominance component. Nominal P-values are reported.
Gene Set Enrichment Analysis of GABA gene sets We used the Gene Set Enrichment Analysis (GSEA) method 89 to test whether two haplotypes that were associated with schizophrenia (GABRA1 Hap10A and GABRA1 Hap10B) were also associated with coordinate alterations in expression of related genes. Details of the analysis are provided in Supplementary  Table 3 . Briefly, for a given pairwise comparison (eg Hap10A þ / þ vs Hap10AÀ/À), we determined whether the expression of a related set of genes (the 'gene set') was coordinately altered (ie, either up-or down-regulated) in one haplotype group compared to the other. To determine nominal significance levels adjusted for the number of genes on the microarray included in the analyses, the category labels of the samples (eg Hap10A þ / þ or Hap10AÀ/À) were randomly permuted 10 000 times, and the observed result was compared with the permutation results. To interpret the results with respect to the number of gene sets and haplotype comparisons tested, we calculated a false discovery rate (FDR), 90 which is the expected proportion of false results (Type I errors) among the results that surpassed a particular significance threshold. The FDR was calculated as nP/R, where n is the number of independent tests, P is the significance threshold applied to the results, and R is the number of reported results that met or surpassed P.
Gene sets were created consisting of coexpressed genes of each of the 5q GABA A receptor subunit genes. For each gene (GABRA1, GABRA6, GABRB2, GABRG2, and GABRP), we derived four gene sets comprised of: (a) the 50 nearest expression neighbors of the gene in the Genomics Institute of the Novartis Research Foundation (GNF) expression atlas version 1 91 (consisting of B12 000 genes), using either all of the tissues or only the brain tissues in the atlas, and (b) the 100 nearest expression neighbors of the gene in the GNF expression atlas version 2 91, 92 (consisting of B22 000 genes), using either all of the tissues or only the brain tissues in the atlas. This resulted in a total of 20 GABA gene sets. The gene sets were named according to the GABA A receptor subunit gene, the atlas version, and the atlas tissues used (eg GABRA1-v1-all tissues).
Peripheral leukocyte microarray samples from the 32 discordant sibpairs were grouped to reflect as closely as possible, given the restriction to two-class comparisons in the GSEA method, three possible genetic effects of the associated haplotypes: Hap þ / þ vs À/À (similar to an additive model but excluding Hap þ /À individuals), Hap þ / þ vs þ /À and À/À (recessive model), or Hap þ / þ and þ /À vs À/À (dominant model). Note that only the Hap þ /À vs HapÀ/À model could be tested for GABRA1 Hap10B, since the corresponding Hap þ / þ homozygous classes were not observed in the sample. We performed a total of 80 tests for haplotype effects on gene set expression (20 GABA gene sets Â four genetic models (Hap10A: three models þ Hap10B: one model)). GSEA was also performed to compare the schizophrenia and unaffected siblings (regardless of the presence of particular haplotypes) for differences in expression of the 20 GABA gene sets.
Analysis of schizophrenia and unaffected sibling pairs Scheffe's tests were performed to identify expression differences between schizophrenia and unaffected siblings in transcripts of the 5q GABA A receptor subunit genes. A paired design was utilized in which expression differences within each sibpair were calculated and subsequently averaged across all sibpairs.
Results
Association between schizophrenia and 5q GABA A receptor subunit genes To test for association with schizophrenia, 132 SNPs spanning the coding regions and B10 kb of flanking sequence of GABRB2, GABRA6, GABRA1, GABRG2, and GABRP were genotyped in a Portuguese sample consisting of parent-proband trios (N ¼ 111), unrelated cases (N ¼ 321), and controls (N ¼ 242). Figure 1 demonstrates the chromosomal order and distances between the genes, with GABRB2, GABRA6, GA-BRA1, and GABRG2 (listed centromeric to telomeric) clustered within an 860-kb region, and GABRP located B8 Mb telomeric to the cluster. Figure 2 displays the SNP positions relative to the five genes. Significant associations were detected between schizophrenia and 19 SNPs (Po0.05) spanning the gene cluster ( Table 2 ). The majority of associated SNPs were in GABRA1, with some in GABRB2, GABRA6, and GABRP. Association results for all 132 SNPs spanning the cluster are provided in Supplementary  Table 4 .
To further investigate these associations, we performed haplotype-based analyses. We determined the pairwise LD between all SNPs and identified 21 haplotype blocks of strong LD spanning the gene cluster ( Figure 2 ). The haplotype blocks averaged Figure 1 Genomic structure of the chromosome 5q GABA A receptor subunit genes tested for association with schizophrenia. Orientation of genes is indicated by direction of arrows. Physical distances between genes are shown. Table 5 . As shown in Table 2 , significant associations (Po0.05) were detected with several haplotypes in the gene cluster. In GABRA1, associations were found with four haplotypes in adjacent haplotype blocks 9 and 10 that span the gene and contain all of the GABRA1 SNPs that were individually associated with schizophrenia. Haplotypes Hap9A in block 9 and Hap10A in block 10 were in excess in patients (parent-proband transmissions and unrelated cases) compared to controls (parent-proband nontransmissions and unrelated controls) (both P ¼ 0.0019). Hap9C and Hap10B were at lower frequencies in patients (P ¼ 0.0013 and 0.027, respectively). Since LD was strong between haplotype blocks 9 and 10 (D 0 ¼ 0.9), we tested haplotypes spanning both blocks for association. Hap9A þ 10A was at higher frequency in patients (P ¼ 0.00086) and Hap9C þ 10B was at lower frequency (P ¼ 0.00062). Associations were also detected with two other 5q GABA A receptor subunit genes. In GABRA6, Hap8C was under-represented (P ¼ 0.0067) in patients compared to controls. In GABRP, a low-frequency (o5%) haplotype, Hap18D, was in excess in patients (P ¼ 0.0024). Adjacent GABRP haplotypes Hap20A and Hap21B were less frequent in patients (P ¼ 0.042 and 0.038, respectively). As shown in Table 2 , comparison of the number of transmissions and nontransmissions in the trios sample, and the frequencies in the case-control sample, found that the haplotype associations were not due to one sample alone, but rather the effects were consistent in the two samples. Frequencies of the above haplotypes were similar in a subset of 31 trios and 59 unrelated cases that had a positive family history, defined as having at least one first-or second-degree relative with schizophrenia (data not shown).
Replication of association between schizophrenia and 5q GABA A receptor subunit genes We sought to replicate the nominally significant Portuguese SNP and haplotype associations in an independent sample of German parent-proband trios (N ¼ 238). As shown in Table 2 , associations were replicated at Po0.05 for three of the 19 SNPs tested: rs168697 in GABRB2 (P ¼ 0.010*), rs1037715 in GABRA1 (P ¼ 0.0015*) and rs7736504 in GABRP (P ¼ 0.023*). Note that these two SNPs were associated in the same manner as the Portuguese sample, in that the alleles found in excess in the Portuguese patients were also overtransmitted to the German probands. We reconstructed haplotypes in the German sample using the same haplotype block structure defined in the Portuguese sample, since the LD structures of the two samples were for the most part identical (data not shown). Of the 10 haplotypes tested, associations were replicated at Po0.05 for four haplotypes in GABRA1 and GABRP (Table 2 ). In GABRA1, risk haplotypes Hap10A and Hap9A þ 10A were overtransmitted to affected probands (P ¼ 0.043* and P ¼ 0.023*, respectively), while Hap10B was undertransmitted to probands (P ¼ 0.0036*). Note that Hap10B is uniquely tagged by the T allele of rs1037715(C/T), one of the two associated SNPs in this sample, in that the T allele was found only on Hap10B and no other haplotypes in block 10 (Supplementary Table 5 ). In GABRP, risk haplotype Hap18D was overtransmitted to probands (P ¼ 0.023*; Table 2 ). This haplotype is uniquely tagged by the A allele of rs7736504(G/A), one of the two SNPs associated in this sample. After stringent Bonferroni correction for the 29 tests (19 SNPs and 10 haplotypes) performed in the German sample, only the association with rs1037715 in GABRA1 remained significant at P ¼ 0.044* (nominal P ¼ 0.0015* Â 29).
Support for association between schizophrenia and GABRB2
We specifically investigated GABRB2 SNPs previously reported to be associated in Chinese schizophrenia patients. 70 None of the SNPs (rs187269, rs252944, rs194072, rs1816071, and rs6556547) were significantly associated in either the Portuguese or German patient samples (all P40.05; Supplementary Table 4 ). The alleles of each of the five SNPS that were at higher frequency in the Chinese cases together comprised a haplotype, Hap3C, found at B8% frequency in our samples. This haplotype was overtransmitted to probands in the German sample (P ¼ 0.035*; Table 2 ), and thereby provided support for the association reported in the previous study.
70
Hap3C was not associated in the Portuguese parentproband trios and case-control sample (P ¼ 0.92; Table 2 ). Post hoc analyses of the Portuguese trios and case-control samples separately found that Hap3C was overtransmitted to trio probands (20 transmissions vs 11 nontransmissions; P ¼ 0.053*), but the cases and controls had similar haplotype frequencies (6.3% cases vs 8.1% controls; P ¼ 0.24).
Effects of haplotypes associated with schizophrenia on GABA A receptor subunit expression levels Disease-associated haplotypes may exert their effect by altering their own expression or the expression of other genes. Thus, we examined whether the haplotypes that we found associated with schizophrenia in both the Portuguese and German samples were related to alterations in transcript levels of the 5q GABA A receptor subunit genes in a sample of 32 discordant sibling pairs. We determined the genotype of each individual for haplotypes GABRA1 Hap10A and GABRA1 Hap10B. We did not test GABRP Hap18D, even though we detected association with this haplotype in both the Portuguese and German samples, because it was too rare to be informative. Haplotypes from all individuals (both affected and unaffected) were analyzed together in order to maximize statistical power. Microarray mRNA expression 5q GABA A receptor genes confer schizophrenia risk TL Petryshen et al levels of each of the five 5q GABA A receptor subunit genes were linearly regressed against genotypes of GABRA1 Hap10A or GABRA1 Hap10B. A significant effect of GABRA1 Hap10A on lower GABRA6 expression was found under a dominant model (P ¼ 0.016, 1 df; Table 3 ), with Hap10A þ / þ and þ /À individuals having 1.7-fold lower expression of GABRA6 compared to Hap10AÀ/À individuals.
Exploration of effects of haplotypes associated with schizophrenia on GABA gene set expression Changes at the transcript or protein level of a GABA A receptor subunit could affect the physiologic state of the cell by altering cell electrical potential and downstream signaling molecules. Thus, we explored whether the associated GABRA1 haplotypes had effects on expression of groups of genes related to the GABA A receptor subunit genes. Since functionally related genes are often coregulated, 93, 94 we created sets of genes based on coexpression with each GABA A receptor subunit gene. Specifically, for each of the five GABA A receptor subunit genes (GABRA1, GABRA6, GABRB2, GABRG2, and GABRP), we created four gene sets using either of two public expression atlases (referred to as 'v1' and 'v2') 91, 92 , and either all tissues or only the brain tissues in each atlas (referred to as 'all tissues' and 'brain'), resulting in a total of 20 gene sets. The 32 discordant sibpairs described above were classified based on presence of a particular haplotype into two categories that reflected additive, dominant, and recessive genetic models (as detailed in the Materials and methods section). For each haplotype-gene set analysis, we used GSEA 89 to examine the microarray mRNA expression data for the presence of gene set members among those genes that were the most differentially expressed between the two haplotype categories compared. Of the total 80 haplotype-gene set comparisons tested, two results were significant at a threshold of Pp0.01. This corresponds to a 40% FDR, thus one of the two results may be false.
Both of the two significant haplotype-gene set results involved GABRA1 Hap10B, which we found under-represented in schizophrenia patients. As reported in Table 3 , Hap10B was related to higher expression of two GABA gene sets: Hap10B þ /À individuals had 1.21-fold higher expression of the GABRA1-v1-all tissues gene set, and 1.25-fold higher expression of the GABRB2-v2-all tissues gene set, compared to Hap10BÀ/À individuals (P ¼ 0.0100 and 0.0014, respectively). Note that the genes in these two gene sets do not overlap, and thus the effects of Hap10B on the gene sets were not due to shared genes. As shown in Table 3 , the GABRA1 gene set primarily contains presynaptic and vesicle-associated proteins, and the GABRB2 gene set contains many neurotransmitter receptors and other receptors. Post hoc analyses of the individual genes in the two gene sets determined that many genes had significant expression differences on their own between the particular haplotype groups (uncorrected Student's Nominal P-value.
5q GABA A receptor genes confer schizophrenia risk TL Petryshen et al t-test PX0.0032; Supplementary Table 3) . Supplementary Table 3 lists the gene set members and their expression fold changes between Hap10B þ /À and Hap10BÀ/À individuals.
Transcript expression alterations in schizophrenia patient peripheral leukocytes Previous studies of postmortem prefrontal cortex from schizophrenia patients have reported alterations in some of the 5q GABA A receptor subunit genes and in GABAergic genes. [95] [96] [97] Therefore, we investigated the discordant sibling pairs for expression differences between the schizophrenia siblings and the unaffected siblings (ie, we tested for an effect of disease, rather than effects of haplotypes as reported above). Linear regression analysis of each of the five GABA A receptor subunit genes detected an average 1.37-fold decrease in GABRA6 transcript expression in the schizophrenia siblings (P ¼ 0.027; Table 3 ). Analysis of the 20 GABA gene sets using GSEA detected an average 1.14-fold decrease of the GABRA1-v1-all tissues gene set in schizophrenia siblings (P ¼ 0.025; FDR ¼ 50%). We have also found that this gene set has lower expression in the prefrontal cortex of schizophrenia patients compared to controls (P ¼ 0.005; unpublished data) in a postmortem sample obtained from the Stanley Medical Research Foundation that has been described previously. 98 Supplementary Table 3 lists the GABRA1 gene set members and their expression fold changes between schizophrenia patients and unaffected individuals.
Discussion
Numerous pharmacological, imaging, and postmortem studies have implicated the GABA system in schizophrenia pathophysiology. [47] [48] [49] The current study has presented several lines of evidence for the specific involvement of GABA A receptor subunit genes located in the 5q schizophrenia risk locus. We detected association between schizophrenia and both GABRA1 and GABRP in a patient sample of Portuguese descent. Importantly, we subsequently replicated the GABRA1 and GABRP associations in an independent sample of German origin. We also obtained supportive evidence for association with GABRB2 that was previously reported in a Chinese patient sample. 70 Furthermore, exploratory analyses suggested that the associated GABRA1 haplotypes had effects on mRNA expression levels of some of the 5q GABA A receptor genes and related groups of genes, including some synaptic and vesicle-associated genes that have been reported to be altered in schizophrenia prefrontal cortex. 96 We detected associations between two GABRA1 haplotypes and schizophrenia in our Portuguese sample that we subsequently replicated in our German sample. A 'risk' haplotype at B50% population frequency, Hap10A, was in excess in the Portuguese patients and was overtransmitted to German probands. In contrast, a 'protective' haplotype at B15% frequency that spanned the same region, Hap10B, was under-represented in Portuguese patients and undertransmitted to German probands. These haplotypes contain the SNP that had the strongest association in our second-stage German sample, which remained significant at Po0.05 after stringent Bonferroni correction for the number of tests performed in this sample. It will be important to determine whether only one of these haplotypes accounts for the observed association; however, to do this effectively requires a much larger sample than we currently have. We also detected associations in both of our patient samples with a rare risk haplotype in GABRP. None of the SNP alleles that uniquely mark these GABRA1 and GABRP haplotypes are known to be functional, and are thus not likely themselves directly responsible for the altered risk of schizophrenia observed, but are likely in LD with other functional or regulatory alleles. Identifying the causal alleles will require further sequencing of these genes to assemble a comprehensive set of sequence variants, followed by genotyping in large, well-characterized populations of schizophrenia patients.
We specifically investigated a GABRB2 risk haplotype containing SNP alleles reported to be in excess in Chinese schizophrenia patients, 70 and obtained modest support for association in our German and Portuguese parent-proband trios samples. The observed association in our trios samples indicates that the Chinese report was unlikely due to population stratification between cases and controls, and likewise our trios results are not likely due to transmission distortion. Association was not detected with this haplotype in our Portuguese case-control sample, however. The reason is unclear, and may only become apparent after additional studies in independent samples are carried out to delineate the role of this haplotype in schizophrenia risk. Evidence has also been presented for association with GABRG2 in Finnish patients; 99 however, the data have not yet been published to permit thorough comparison with our findings. Other 5q GABA A receptor subunit gene haplotypes were also associated in our Portuguese sample but were not replicated in the German sample, suggesting that the Portuguese associations may be Type I errors. However, investigation of these haplotypes in other patient samples may be necessary to conclusively rule out their involvement in schizophrenia.
Our results and those of others 70, 99 suggest that the functionally related GABRA1, GABRB2, GABRG2, and GABRP genes on chromosome 5q may all confer risk of schizophrenia. This finding is not overly surprising since the first three genes encode subunits that associate together in the major GABA A receptor in the adult brain, 100, 101 and the latter gene encodes a regulatory subunit that modulates the effects of drugs on the receptor. 41 Given that these subunits associate together in a receptor, epistatic interactions between subunit genes are possible. However, investigation of interactions will require larger samples than we 5q GABA A receptor genes confer schizophrenia risk TL Petryshen et al currently have in order to achieve adequate statistical power, particularly for less frequent haplotypes (eg our Portuguese sample had o75% power to detect interactions between the GABRA1 and GABRB2 haplotypes).
Gene polymorphisms that are involved in disease susceptibility may function by altering the encoded polypeptide sequence, transcript expression levels, or temporal expression patterns, for example. Expression alterations may occur either by a sequence variant in a gene dictating the level of transcription of the gene itself, or the processing or stability of its mRNA transcript. Alternatively, a gene sequence variant may alter the expression of other genes. Changes in the expression level or encoded protein of a GABA A receptor subunit could affect the physiologic state of the cell through alterations in cell electrical potential and downstream signaling molecules, since the GABA A receptors flux chloride. Such changes could affect regulation of a multitude of genes through various signal transduction pathways.
Our exploratory analyses of the effects of GABRA1 haplotypes that we found associated with schizophrenia on expression of the GABA genes and GABArelated gene sets produced several interesting findings. We did not detect significant effects of the haplotypes on expression of their own transcripts, although our sample may have insufficient power to detect such effects, particularly for less frequent haplotypes. However, we did observe potential effects of the haplotypes on expression levels of other 5q GABA subunit genes and coexpressed genes. Specifically, the GABRA1 Hap10A risk haplotype was correlated with lower expression of the GABRA6 gene, and the GABRA1 Hap10B protective haplotype was related to coordinate expression alterations in gene sets that are coexpressed with GABRA1 and GABRB2. Furthermore, many of the genes in these two gene sets on their own had nominally significant expression differences between the haplotype groups. These preliminary findings suggest that one or more sequence variants residing on haplotypes of GABRA1 function to regulate biological pathways in which itself and the GABRB2 gene, which we and others 70 have implicated in schizophrenia risk, may operate. However, determination of the exact nature of the relationship between these haplotypes, the altered biological pathways, and the pathophysiological findings observed in the brains of schizophrenia patients requires further investigation. Interestingly, the altered GABRA1 gene set primarily consist of synaptic and vesicle-associated proteins (eg dynamin, N-ethylmalemide-sensitive factor (NSF), synaptotagmin, synaptogyrin, and synaptophysin), many of which have previously been reported to be downregulated in schizophrenia prefrontal cortex. 96 The altered GABRB2 gene set contains a more diverse set of primarily membrane-bound and extracellular proteins, including neurotransmitter receptors (eg 5-hydroxytryptamine receptor 1F, nicotinic acetylcholine receptor beta 3, GABA receptor rho 2 subunit, GABA receptor theta subunit, and N-methyl-D-aspartate receptor 2A subunit (GRIN2A)) and other receptors (eg retinoic acid receptor beta, retinoid X receptor gamma, estrogen-related receptor alpha, and fibroblast growth factor receptor 2).
Lower expression of presynaptic secretory machinery has been postulated as a specific schizophreniarelated defect. 102 Our results demonstrated that a GABRA1 gene set which, as described above, contains many synaptic and vesicle-associated genes, was coordinately decreased an average of 1.14-fold in schizophrenia siblings compared to unaffected siblings. Further support for this defect has been found in our unpublished observations, in which this gene set has lower expression in the prefrontal cortex of schizophrenia patients compared to controls in a postmortem sample obtained from the Stanley Medical Research Foundation.
We point out two important considerations in interpreting our mRNA expression results. The first is that we applied nominal significance thresholds to our gene set analysis results that were adjusted for the large number of genes on the microarray, but were not corrected for the number of comparisons performed. Therefore, to interpret our results in light of the multiple tests, we determined the FDR for our analyses. The FDR's were 40 and 50% for our haplotype-based and disease-based gene set analyses, respectively, indicating that one of the two significant gene sets in the haplotype-based analyses, and the only significant gene set in the disease-based analyses, may be false positives. The second consideration is that, as we have discussed previously, 59 we utilized peripheral leukocytes isolated from blood, rather than postmortem brain tissue. Our rationale is that artefacts introduced by postmortem hypoxia, anatomical inconsistencies, and postmortem interval in postmortem tissue studies are not an issue with leukocyte samples. However, it is unknown the extent to which this cell population reflects transcript expression profiles of the brain. Nonetheless, many brain-related genes and metabolic transcripts that have altered expression in schizophrenic postmortem prefrontal cortex are also altered in peripheral tissues, including lymphocytes, [103] [104] [105] arguing for the validity of using peripheral leukocytes to measure schizophrenia gene expression alterations. Of relevance to the current study, murine T lymphocytes express functional GABA A receptors that are pharmacologically similar to their central nervous system counterparts, 106 and GABA receptors have been found in pancreatic islets, the gastrointestinal tract, ovaries, and the adrenal medulla. 107 Furthermore, we detected significant haplotype effects on gene sets containing synaptic and vesicle-associated genes that have previously been implicated in schizophrenia, 96 indicating that genes that are typically considered brain-specific are in fact expressed in peripheral leukocytes. Clearly, the next step will be to determine in a large postmortem brain sample whether the 5q GABA A receptor genes confer schizophrenia risk TL Petryshen et al haplotypes also affect these GABA-related pathways in the brain. Interestingly, a recent study found that treatment of the rat hippocampus with NRG1 resulted in significantly lower mRNA expression of the GABA A receptor alpha 1 and alpha 2 subunits, and modestly decreased GABA A receptor beta 2 and gamma 2 subunit expression. 66 Furthermore, different isoforms of NRG1 appear to act as attractants for migrating cortical GABAergic interneurons. 108 These findings are highly intriguing given the reported association between the NRG1 gene and schizophrenia, 33, [52] [53] [54] [55] [56] [57] [58] [59] and suggest that defects in GABA A receptor regulation by NRG1 is a possible mechanism by which NRG1 contributes to schizophrenia. Indeed, in a previous study using the same 33 discordant sibpairs as in the present study, we found higher expression of the SMDF isoform of NRG1 in subjects with schizophrenia. 59 Thus, the conferred risk of schizophrenia by NRG1 and the 5q GABA A receptor subunit genes may be through a common GABA-related pathway, lending support to the GABA hypothesis of schizophrenia pathophysiology.
In conclusion, the current study has obtained evidence from multiple fronts that the GABA A receptor subunit genes located on chromosome 5q are involved in schizophrenia risk and pathophysiology. We have presented evidence for replicated associations between two GABA A receptor subunit genes and schizophrenia in two European samples, the most compelling results being for GABRA1. Our study also provides modest support for a previously reported GABRB2 association. Furthermore, we found relationships between associated GABRA1 haplotypes and expression levels of GABA genes, as well as gene sets that may be coregulated with the GABA genes. Taken together with historical and more recent data implicating the GABA system in schizophrenia, our data suggest that further investigations of these genes are warranted to understand the complex role that the GABA subunits and related genes play in schizophrenia pathogenesis.
